ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden · Delayed Price · Currency is SEK 2.460
-0.140 (-5.38%)
May 21, 2026, 12:20 PM CET
STO:EXPRS2 Market Cap
STO:EXPRS2 has a market cap or net worth of 9.18 million as of May 21, 2026. Its market cap has decreased by -82.17% in one year.
Market Cap
9.18M
Enterprise Value
-37.02M
Revenue
10.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.46
Market Cap Chart
Since July 29, 2016, STO:EXPRS2's market cap has decreased from 117.71M to 9.18M, a decrease of -92.20%. That is a compound annual growth rate of -22.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 9.18M | -83.65% |
| Dec 30, 2025 | 56.13M | 29.73% |
| Dec 30, 2024 | 43.27M | -60.11% |
| Dec 29, 2023 | 108.46M | -82.55% |
| Dec 30, 2022 | 621.64M | -45.72% |
| Dec 30, 2021 | 1.15B | 280.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pila Pharma AB | 82.00M |
| Alzinova AB | 68.11M |
| Modus Therapeutics Holding AB | 59.84M |
| 2cureX AB | 54.22M |
| Fluicell AB | 41.62M |
| Guard Therapeutics International AB | 26.82M |
| Biosergen AB | 22.90M |
| NanoEcho AB | 17.94M |